2017
DOI: 10.7150/jca.18171
|View full text |Cite
|
Sign up to set email alerts
|

Chemoresistance of colorectal cancer to 5-fluorouracil is associated with silencing of the BNIP3 gene through aberrant methylation

Abstract: Purpose To investigate the correlation between chemoresistance of colorectal cancer to 5-fluorouracil and BNIP3 and the underlying mechanism.Methods BNIP3 protein in specimens was evaluated using immunohistochemistry. Semi-quantitative reverse transcription PCR and Western blot was employed to assay gene expression. The promoter methylation status of BNIP3 was examined by methylation-specific PCR. Drug sensitivity was assayed using MTT assay.Results Specimens from 81 patients with colorectal cancer receiving 5… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
41
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(45 citation statements)
references
References 32 publications
4
41
0
Order By: Relevance
“…We can also hypothesize that the level of BNIP3 protein modifies the response to some kind of cellular stress and a decrease in the BNIP3 pro-apoptotic protein level in our LHON cell model, could negatively affect apoptosis induction, what in turn can lead to cell survival as in the case of BNIP3-negative cancer cells (He et al, 2017;Li et al, 2017). Our analyses of lymphoblasts with the 11778G>A mutation treated with different concentrations of testosterone could support this hypothesis.…”
Section: Discussionsupporting
confidence: 58%
See 2 more Smart Citations
“…We can also hypothesize that the level of BNIP3 protein modifies the response to some kind of cellular stress and a decrease in the BNIP3 pro-apoptotic protein level in our LHON cell model, could negatively affect apoptosis induction, what in turn can lead to cell survival as in the case of BNIP3-negative cancer cells (He et al, 2017;Li et al, 2017). Our analyses of lymphoblasts with the 11778G>A mutation treated with different concentrations of testosterone could support this hypothesis.…”
Section: Discussionsupporting
confidence: 58%
“…Decreased expression of BNIP3 in some cases of cancers was found to be caused by epigenetic modification, hypermethylation, of the BNIP3 promoter (Okami et al, 2004;Lazarini et al, 2012;Li et al, 2017). Treatment of BNIP3-negative pancreatic and colorectal cancer cell lines with a DNA methylation inhibitor restored BNIP3 expression and increased chemosensitivity and cell death in those cell lines (He et al, 2017;Li et al, 2017). In our studies the methylation profile was not checked and the cause of the lower level of BNIP3 in LHON cybrids requires further investigation.…”
Section: Discussionmentioning
confidence: 63%
See 1 more Smart Citation
“…Bcl-2 interacting protein 3 (BNIP3) is another hypoxia-regulated protein belonging to the BH3-only Bcl-2 family that has proven to be involved in apoptosis, necrosis, autophagy, and mitophagy under hypoxia or ischemia [10,11]. BNIP3, which may be activated by HIF-1α due to its HREs-containing promoter, is expressed in hypoxic tumoral areas, contributing to hypoxia-induced cell death [12].…”
Section: Introductionmentioning
confidence: 99%
“…Despite an enormous amount of effort spent in the development of therapies to treat CRC, the 5-year survival rate has increased slowly in the USA, from 60% during the 1980s to 66% during 2005 to 2011 (4). To a large extent, this discouraging observation is largely due to the fact that patients with CRC demonstrate resistance to both new and older anticancer drugs (3,5).…”
Section: Introductionmentioning
confidence: 99%